Amarna Therapeutics Appoints Dr. Henk Streefkerk as CEO, Driving Transformative Gene Therapies

Leiden, Netherlands, June 7, 2023 (PRNewswire) -- Amarna Therapeutics, a pioneering biotech company specializing in gene therapies, announces the appointment of Dr. Henk Streefkerk as the new Chief Executive Officer and Medical Director. With his extensive experience in clinical development and regulatory interactions, Dr. Streefkerk will lead Amarna in advancing personalized gene therapies, starting with the treatment of Hemophilia B, and proving the potential of repeat dosing for improved patient outcomes.

Read full article here.